Events

E.g., 02/25/2026

  • Hematological Malignancies Seminar Series: Diane Krause, MD, PhD

    Tuesday, March 3, 2026
    1:15 PM to 2:15 PM
    Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 1st Floor Auditorium
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    Diane Krause, MD, PhD,  Anthony N. Brady Professor of Laboratory Medicine, Pathology, and Cell Biology Medical Director, Clinical Cell Processing Laboratory and the Advanced Cell Therapy Laboratory Associate Medical Director, Transfusion Medicine Associate Director, Yale Stem Cell Center Title: "Mechanisms of Hematopoietic Fate Specification to Megakaryocytes" Hosted by Stavroula Kousteni, PhD, Professor, Department of Physiology & Cellular Biophysics; Director, Evans MDS Center at Columbia. This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.

  • Hematological Malignancies Special Seminar: Dr. Katja Klausz

    Thursday, March 5, 2026
    4:00 PM to 5:00 PM
    Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 1st Floor Auditorium
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    Dr. Katja Klausz Division of Antibody-Based Immunotherapy; Department of Internal Medicine II University Medical Center Schleswig-Holstein – Kiel Campus Title: "Targeting B Cell Neoplasia: Development and Pre-Clinical Evaluation of Novel Antibody-Based Immunotherapies" Hosted by Jing Fu, PhD and Suzanne Lentzsch, MD, PhD. This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.

  • Hematological Malignancies Seminar Series: Martin Carroll, MD

    Tuesday, March 24, 2026
    1:15 PM to 2:15 PM
    Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 1st Floor Auditorium
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    Speaker: Martin Carroll, MD, Associate Professor of Medicine (Hematology-Oncology), Medical Director, University of Pennsylvania, Perelman School of Medicine Hosted by Stavroula Kousteni, PhD, Professor, Department of Physiology & Cellular Biophysics; Director, Evans MDS Center at Columbia. This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.

  • Hematological Malignancies Seminar Series: Britta Will, PhD

    Tuesday, April 28, 2026
    1:15 PM to 2:15 PM
    Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 1st Floor Auditorium
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    Speaker: Britta Will, PhD, Associate Professor, Departments of Oncology (Medical Oncology), Medicine, Cell Biology, the Ruth L & David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine; Ruth L. and David S. Gottesman Chair in Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine Hosted by Emmanuelle Passegue, PhD, Alumni Professor of Genetics and Development; Director, Columbia Stem Cell Initiative. This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.

  • Hematological Malignancies Seminar Series: Christopher Mason, PhD

    Tuesday, May 26, 2026
    1:15 PM to 2:15 PM
    Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 1st Floor Auditorium
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    Speaker: Christopher Mason, PhD, Professor of Physiology and Biophysics, Director WorldQuant Initiative for Quantitative Prediction and WorldQuant Foundation Research Scholar, Professor of Computational Biomedicine in the Institute of Computational Biomedicine, Professor of Neuroscience in the Brain and Mind Institute, Weill Cornell Medicine Hosted by Aaron Viny, MD, Assistant Professor of Medicine at CUIMC. This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.

  • Hematological Malignancies Seminar Series: Saar Gill, MD, PhD

    Tuesday, June 23, 2026
    1:15 PM to 2:15 PM
    Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 1st Floor Auditorium
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    Speaker: Saar Gill, MD, PhD, Associate Professor of Medicine in the Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine Hosted by Stavroula Kousteni, PhD, Professor, Department of Physiology & Cellular Biophysics; Director, Evans MDS Center at Columbia. This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.